Can-Fite BioPharma annual current ratio
2017
2018
2019
2020
2021
2022
2023
2024
2025
Can-Fite BioPharma Current Ratio Growth & History (CANF)
Can-Fite BioPharma's current ratio was 3.46 for fiscal 2025.
View full Can-Fite BioPharma company overviewCan-Fite BioPharma annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 3.46 | −0.92 | −21.03% |
| 2024 | 2024-12-31 | 4.38 | −0.53 | −10.76% |
| 2023 | 2023-12-31 | 4.90 | 1.25 | +34.02% |
| 2022 | 2022-12-31 | 3.66 | −3.69 | −50.21% |
| 2021 | 2021-12-31 | 7.35 | −0.06 | −0.76% |
| 2020 | 2020-12-31 | 7.41 | 5.22 | +239.16% |
| 2019 | 2019-12-31 | 2.18 | −0.35 | −13.80% |
| 2018 | 2018-12-31 | 2.53 | −1.27 | −33.31% |
| 2017 | 2017-12-31 | 3.80 | — | — |
Can-Fite BioPharma quarterly current ratio
Q4.17
Q2.18
Q4.18
Q2.19
Q4.19
Q2.20
Q4.20
Q2.21
Q4.21
Q2.22
Q4.22
Q2.23
Q4.23
Q2.24
Q4.24
Q2.25
Q4.25
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | 3.46 | −0.92 | −21.03% |
| Q2 2025 | 2025-06-30 | 3.60 | 0.66 | +22.61% |
| Q4 2024 | 2024-12-31 | 4.38 | −0.53 | −10.76% |
| Q2 2024 | 2024-06-30 | 2.93 | −1.95 | −39.96% |
| Q4 2023 | 2023-12-31 | 4.90 | 1.25 | +34.02% |
| Q2 2023 | 2023-06-30 | 4.89 | −1.89 | −27.90% |
| Q4 2022 | 2022-12-31 | 3.66 | −3.69 | −50.21% |
| Q2 2022 | 2022-06-30 | 6.78 | 2.73 | +67.33% |
| Q4 2021 | 2021-12-31 | 7.35 | −0.06 | −0.76% |
| Q2 2021 | 2021-06-30 | 4.05 | −4.41 | −52.15% |
| Q4 2020 | 2020-12-31 | 7.41 | 5.22 | +239.16% |
| Q2 2020 | 2020-06-30 | 8.46 | 4.99 | +143.49% |
| Q4 2019 | 2019-12-31 | 2.18 | −0.35 | −13.80% |
| Q2 2019 | 2019-06-30 | 3.48 | −0.75 | −17.84% |
| Q4 2018 | 2018-12-31 | 2.53 | −1.27 | −33.31% |
| Q2 2018 | 2018-06-30 | 4.23 | — | — |
| Q4 2017 | 2017-12-31 | 3.80 | — | — |
Can-Fite BioPharma current ratio trends
Over the last five fiscal years, Can-Fite BioPharma's current ratio decreased from 7.41 to 3.46, a change of −3.95. The latest reported quarter, Q4 2025, shows 3.46.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Can-Fite BioPharma source filings ↗